Title:** Silo Pharma Expands AI Offerings; Nvidia Focuses on Buybacks Amid Valuation Compression
Silo Pharma (Nasdaq: SILO), a developmental-stage biopharmaceutical company, has made significant strides in enhancing its artificial intelligence platform through its subsidiary, QwikAgents. Announced on September 30, 2026, this expansion includes...




